Cell-based therapy for insulin-dependent diabetes mellitus.
about
[Morphologic evaluation and Ca2+ mobilization by glicose and acetylcholine in human pancreatic cells].Gene- and cell-based therapeutics for type I diabetes mellitus.Dominant negative MyD88 proteins inhibit interleukin-1beta /interferon-gamma -mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells.Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion.
P2860
Cell-based therapy for insulin-dependent diabetes mellitus.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Cell-based therapy for insulin-dependent diabetes mellitus.
@en
type
label
Cell-based therapy for insulin-dependent diabetes mellitus.
@en
prefLabel
Cell-based therapy for insulin-dependent diabetes mellitus.
@en
P356
P1476
Cell-based therapy for insulin-dependent diabetes mellitus.
@en
P304
P356
10.1530/EJE.0.1380129
P50
P577
1998-02-01T00:00:00Z